First Interstate Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

First Interstate Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-184	Closed	-$40K	–	475
2019 Q4	$40K	Sell	184 -500	-73%	-$101K	0.01%	286
2019 Q3	$116K	Hold	684	–	–	0.03%	235
2019 Q2	$126K	Hold	684	–	–	0.03%	238
2019 Q1	$126K	Buy	684 +184	+37%	+$34K	0.03%	244
2018 Q4	$83K	Hold	500	–	–	0.02%	288
2018 Q3	$96K	Sell	500 -500	-50%	-$89K	0.02%	283
2018 Q2	$170K	Sell	1,000 -50	-5%	-$7.75K	0.04%	203
2018 Q1	$171K	Hold	1,050	–	–	0.04%	201
2017 Q4	$157K	Hold	1,050	–	–	0.03%	211
2017 Q3	$160K	Hold	1,050	–	–	0.03%	209
2017 Q2	$135K	Sell	1,050 -250	-19%	-$30.1K	0.03%	226
2017 Q1	$142K	Hold	1,300	–	–	0.03%	222
2016 Q4	$96K	Buy	1,300 +1,250	+2,500%	+$102K	0.02%	273
2016 Q3	$4K	Hold	50	–	–	﹤0.01%	682
2016 Q2	$4K	Hold	50	–	–	﹤0.01%	662
2016 Q1	$4K	Hold	50	–	–	﹤0.01%	667
2015 Q4	$6K	Hold	50	–	–	﹤0.01%	640
2015 Q3	$5K	Buy	+50	New	+$6.42K	﹤0.01%	680

Other funds holding VRTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

First Interstate Bank's VRTX Position: Q1 2020 in Review

First Interstate Bank sold out of Vertex Pharmaceuticals (VRTX) in Q1 2020, closing a stake of 184 shares — an estimated $40K sold.

First Interstate Bank first reported a position in VRTX in Q3 2015 and held it in 18 quarters. The position peaked at $171K in Q1 2018. 854 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

First Interstate Bank reported no remaining Vertex Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
First Interstate Bank sold 184 Vertex Pharmaceuticals shares in Q1 2020, an estimated $40K.
First Interstate Bank first reported a position in Vertex Pharmaceuticals in Q3 2015 and held it in 18 quarters.
First Interstate Bank's Vertex Pharmaceuticals position peaked at $171K in Q1 2018.
854 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on First Interstate Bank's 13F filing for Q1 2020, filed 11 May 2020.